Agilent Technologies' and PREMIER Biosoft's Platforms Work Together to Advance Lipidomics Research
Complementary Tools Eliminate Bottlenecks in Data Processing and Analysis to advance research in lipidomics.
Online PR News – 07-November-2012 –Santa Clara and Palo Alto, California -- October 26, 2012: Agilent Technologies Inc. (NYSE: A) and PREMIER Biosoft today announced that they will each support the combined use of their respective technologies to help clinical researchers advance lipidomics research. By integrating complementary technologies, researchers can seamlessly generate and process data, then map complex lipidomic networks to learn more about lipid metabolism associated with disease.
The power of Agilent's industry-leading time-of-flight and quadrupole time-of-flight mass spectrometers and Pathway Architect software combined with Premier Biosoft's SimLipid 3.3 identification and quantification software enables researchers to overcome many of the obstacles inherent in lipid identification and analysis. This will give them a distinct advantage in their efforts to map the lipid pathways associated with metabolic disease.
"Just as challenging as mapping and sequencing the human genome is identifying and sequencing the thousands of lipid species involved in human metabolism," said Dr. Daniel B. Kassel, Agilent's senior director of LC/MS global marketing. "By utilizing this combined network of technologies, researchers can be confident in the analytical strength they have come to expect from Agilent and from the advanced lipid identification capabilities provided in PREMIER Biosoft's SimLipid software."
Information on SimLipid 3.3 is available at www.premierbiosoft.com/lipid/index.html.
About PREMIER Biosoft
About Agilent Technologies
Shonali Paul, PREMIER Biosoft
Copyright 2013 Online PR Media | PO Box 5043 | La Quinta, CA 92248